Oscar Aguilar-Sopeña

5PUBLICATIONS
58CO-AUTHORS
Medical devicesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 24, 2026
A Drug-Gated, Modular STAb-T Immunotherapy With External Control.

|Feb 14, 2024
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas

|Apr 01, 2022
Overcoming CAR-Mediated CD19 Downmodulation and Leukemia Relapse with T Lymphocytes Secreting Anti-CD19 T-cell Engagers.

Belén Blanco, Ángel Ramírez-Fernández, Clara Bueno

|Mar 31, 2022
Synapse topology and downmodulation events determine the functional outcome of anti-CD19 T cell-redirecting strategies.

Ángel Ramírez-Fernández, Óscar Aguilar-Sopeña, Laura Díez-Alonso

|Feb 14, 2022
Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer.

Antonio Tapia-Galisteo, Íñigo Sánchez Rodríguez, Oscar Aguilar-Sopeña

Pageof 1

Frequent Collaborators

5 joint publications

Luis Álvarez-Vallina

4 joint publications

Belén Blanco

3 joint publications

Antonio Tapia-Galisteo

3 joint publications

Laura Rubio-Pérez